Adaptive Biotechnologies Earnings
NASDAQ: ADPTHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Wed, Nov 4, 2026
Fiscal period
Sep/2026
EPS estimate
$-0.10
Adaptive Biotechnologies earnings summary
Adaptive Biotechnologies is scheduled to report Sep/2026 earnings on Nov 4, 2026, with analysts expecting EPS of $-0.10. In its most recent report on Aug 4, 2026 (Q2 2026), ADPT posted EPS of $-0.25. Revenue for the quarter was $71.6 million.
Across the last 16 reports, ADPT shares moved an average of 7.2% (in either direction) in the first trading session after results, rising 6 times and falling 10 times.
Summary generated from market data by MetaCap's automated system. Methodology
ADPT earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 4, 2026 | — | $-0.25 | — | -0.8% |
| May 5, 2026 | — | $-0.13 | — | -7.1% |
| Feb 26, 2026 | — | $-0.08 | — | -7.2% |
| Nov 5, 2025 | — | $0.06 | — | -4.7% |
| Aug 5, 2025 | — | $-0.17 | — | +6.9% |
| May 1, 2025 | — | $-0.20 | — | -8.2% |
| Mar 3, 2025 | — | $-0.22 | — | -1.0% |
| Nov 7, 2024 | — | $-0.22 | — | -12.7% |
| Aug 1, 2024 | — | $-0.31 | — | +4.0% |
| May 7, 2024 | — | $-0.33 | — | +3.1% |
| Feb 29, 2024 | — | $-0.48 | — | -9.4% |
| Nov 9, 2023 | — | $-0.35 | — | +22.8% |
| Aug 2, 2023 | — | $-0.33 | — | -7.8% |
| May 3, 2023 | — | $-0.40 | — | +1.7% |
| Feb 14, 2023 | — | $-0.27 | — | -12.4% |
| Nov 3, 2022 | — | $-0.32 | — | +5.1% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.